FDA Advisory Committee does not recommend that sotagliflozin receive approval for glucose lowering in adults with type 1 diabetes (T1D) and Chronic Kidney Disease (CKD)
Update – November 22, 2024 This morning, Lexicon Pharmaceuticals, Inc. (Lexicon) announced they received a “deficiencies preclude discussion” letter from…
Novel way to protect transplanted cells shows promise
A novel immune therapy called tegoprubart made by Eledon Pharmaceuticals and being tested in kidney transplant patients has the potential…
Breakthrough T1D shares the latest research at ISPAD
At the 2024 International Society for Pediatric and Adolescent Diabetes (ISPAD) Conference in Lisbon, Portugal, the world’s leading diabetes researchers,…
Celebrating Halloween with type 1 diabetes
Tips for families on juggling type 1 diabetes with the super sweet fun of Halloween.
Breakthrough T1D and the Nobel Prizes: Connected!
It’s early October, which means the Nobel Prizes are being awarded in several categories. These prestigious awards recognize outstanding contributions…
Stem Cell-Derived Islets Show Promise In Another Study
A new study published in Cell and summarized in Nature has shown positive results using stem cell-derived islets to restore…
New ICD-10 Codes Will Help the T1D Community
On October 1st, the T1D community got a big win: the Centers for Medicare and Medicaid Servies (CMS) introduced a…
Celebrating Hispanic Heritage Month
Breakthrough T1D celebrates Hispanic Heritage Month by honoring the history, achievements, and contributions of our Hispanic communities.
EASD highlights Breakthrough T1D research
The research presented at EASD covered Breakthrough T1D’s entire research portfolio, encompassing disease-modifying therapies, cell therapies, and complications.
Veronica Beard Gives Back to Breakthrough T1D
New York-based fashion brand Veronica Beard is giving back to the type 1 diabetes community through customer donations, in-store events,…
